APAC OTC Ophthalmology Products Market Analysis

$3,500.00$7,500.00

  • Type: Common Disease Area
  • Published : February 2022
  • Region: APAC
  • Country: Other
  • Report ID : 5045

  • Format: PPT, PDF

APAC OTC Ophthalmology Products Market: Segmented by Therapeutic, Product, Distribution Channel, Disease Indication, Dosages, Technology and country- Growth, Market Size, Future Prospects & Competitive Analysis, 2020 – 2028

Clear
SKU: 5045 Categories: ,

Report Description of the APAC OTC Ophthalmology ProductsMarket

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approaches for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Research Objective:

  • To analyze and forecast the market size of APAC OTC Ophthalmology Products market
  • To classify and forecast APAC OTC Ophthalmology Products market based on application, drugs, project type, and application.
  • To identify drivers and challenges for APAC OTC Ophthalmology Products market
  • To examine competitive developments such as mergers and acquisitions, agreements, collaborations, and partnerships, etc., in APAC OTC Ophthalmology Products Drugs market
  • To conduct pricing analysis for APAC OTC Ophthalmology Products Drugs market
  • To identify and analyze the profile of leading players operating in APAC OTC Ophthalmology Products market

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for Renal Cell Carcinoma drug market
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the Renal Cell Carcinoma market
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do deep dive research and also provide strategy-based consulting analysis

APAC OTC Ophthalmology Products Market Executive Summary

Ophthalmology is a branch of medical science that deals with the structure, function, and various eye diseases. It is used to identify ocular defects or deficiencies and treat eye disorders. Ophthalmic devices are medical equipment designed for diagnosis, surgery, and vision correction. Whereas, the ophthalmic diagnostic devices are gaining increased importance and adoption due to surge in prevalence of various ophthalmic diseases such as glaucoma, cataract, and other vision-related issues in the emerging countries.

Market Size and Key Findings

The APAC OTC Ophthalmology Products market size is at around USD 7.10 billion in 2021 and is projected to reach USD 9.91 billion by 2026, exhibiting a CAGR of 6.9% during the forecast period.

The Asia Pacific is the fastest-growing market. As a result, the ophthalmology products market is expected to witness significant growth during the forecast period. The market growth is attributed to the expanding patient population suffering from vision disorders, advanced medications for treating ophthalmic diseases and improving the healthcare sector The growth contributors in the region are China, India, China, Japan, and Australia.

Market Dynamics

Market Growth Drivers Analysis

The growth of the APAC ophthalmic drugs market is majorly driven by the rising number of individuals suffering from glaucoma and tremendous innovation and funding in developing combination therapies. In addition, the ocular pharmaceuticals market is driven by increased FDA approvals, which raises medication approvals and increases surgeries in the ophthalmology industry due to the high prevalence of reactive defects. In addition, the market is expanding as the population ages, the incidence of eye disorders rises, healthcare spending rises, and the use of minimally invasive surgeries rises.

Market Restraints

the development of new pharmaceuticals is impeded by undesirable side effects and long gestation periods, limiting market expansion. Two issues limit the industry’s growth, well-known pharmaceuticals falling off-patent and big players being hampered by the time it takes for new drugs to join the market. In addition, risks associated with ocular disorders and the lack of public understanding of ophthalmology threaten the market.

Competitive Landscape

Key Players

A few promising companies in the Asia-Pacific ophthalmic drugs market profiled in this report are Carl-Zeiss AG, Ellex Medical Lasers Ltd., Hoya Corporation, Novagali Pharma S A. Abbott Medical Optics, Inc., Essilor International SA Other players in the market include insight Vision Inc. Nidek Co.Ltd, Topcon Corporation, and Ziemer Ophthalmic Systems AG

Products in Pipeline

There are currently five molecules in the Pre-registration stage of development that are expected to be granted approval within the forecast period. Two of these are indicted for DES and three for glaucoma. Nearly 36% of the pipeline for glaucoma and DES are molecules in the late stages of development (Phases II and III), and of these, 21 molecules (43%) are indicated for DES and 28 (57%) for glaucoma.

Notable Recent Deals

SUWON, Republic of Korea and CLERMONT-FERRAND, OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, announced a collaboration with Théa Open Innovation, a sister company of Laboratoires Théa S.A.S (“Théa”), the leading independent pharmaceutical company in Europe dedicated to ophthalmology, to develop OliX’ lead pipeline products OLX301A and OLX301D in Age-related Macular Degeneration (AMD) and subretinal fibrosis along two other ophthalmic pipelines upon exercise of the option. As a part of the collaborative agreement, Théa will have worldwide rights excluding Asia-Pacific for four programs.

Healthcare Policies and Regulatory Landscape

Pricing and Reimbursement scenario of OTC Ophthalmology Products supplements

Many Asian countries are working towards UHC, their plans vary greatly in scope and service provision, with different degrees of out-of-pocket expenditures. Coverage of the latest ophthalmological technologies and procedures is often limited. In the case of Minimally Invasive Glaucoma Surgery (MIGS), for example, availability and reimbursement levels for different technologies varies considerably across the region Moreover, most national reimbursement systems only cover the direct medical costs of surgery and medications. Patients in these countries may still have to cover non-medical costs like travel and lodging, as well as indirect costs from loss of income for the time spent seeking treatment.

1. Report Description of the APAC OTC Ophthalmology ProductsMarket
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. APAC OTC Ophthalmology ProductsMarket Executive Summary
2.1 APAC OTC Ophthalmology ProductsMarket – Industry Snapshot & key buying criteria, 2020-2028
2.2 Market Size, Growth Prospects, and Key findings
3. Market Dynamics of APAC OTC Ophthalmology ProductsMarket
3.1 Market Growth Drivers Analysis
3.1.1 Rising number of individuals suffering from glaucoma
3.1.2 Innovation and funding in developing combination therapies
3.1.3 Increased FDA approval
3.1.4 Rising population ages
3.1.5 Technological advancements in Diagnosis and Imaging Techniques
3.2 Market Restraints Analysis
3.2.1 Side effects and long gestation period
3.2.2 Falling off the patent of products
3.2.3 Risk associated with ocular disorders
3.2.4 Lack of public understanding of ophthalmology
4. OTC Ophthalmology Products Market Segmentation
4.1 By Therapeutic Class Analysis:
4.1.1 Anti-inflammatory Drugs
4.1.2 Anti-infective Drugs
4.1.3 Anti-glaucoma Drugs
4.1.4 Anti-allergy Drugs
4.1.5 Anti-VEGF Agents
4.1.6 Others
4.2 By Product Type Analysis:
4.2.1 Prescription Drugs
4.2.2 Over-the-Counter Drugs
4.3 By Distribution Channel Type Analysis:
4.3.1 Hospital Pharmacies
4.3.2 Online Pharmacies
4.3.3 Independent Pharmacies
4.3.4 Drug Stores
4.4 By Disease Indication Analysis:
4.4.1 Dry Eyes
4.4.2 Glaucoma
4.4.3 Infection/Inflammation
4.4.4 Retinal Disorders
4.4.5 Allergy
4.4.6 Uveitis
4.4.7 Others
4.5 By Dosage Type Analysis:
4.5.1 Liquid Ophthalmic Drugs Forms
4.5.2 Solid Ophthalmic Drugs Forms
4.5.3 Semisolid Ophthalmic Drugs
4.5.4 Multicompartment Drug Delivery System
4.6 By Technology Type Analysis:
4.6.1 Biologics
4.6.2 Cell Therapy
4.6.3 Gene Therapy
4.6.4 Drug Therapy
4.6.5 Small Delivery
4.6.6 Small Molecule
4.6.7 Others
4.7 By Country Type Analysis:
4.7.1 India
4.7.2 China
4.7.3 Japan
4.7.4 South Korea
4.7.5 Australia
4.7.6 New Zealand
4.7.7 Malaysia
4.7.8 Vietnam
4.7.9 Philippines
4.7.10 Indonesia
4.7.11 Singapore
4.7.12 Rest of APAC
5. OTC Ophthalmology Products Products Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives in OTC Ophthalmology Products Market
6.4 Notable recent deals in OTC Ophthalmology Products Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers &Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Carl-Zeiss AG Company Overview
Product & Services, Strategies & Financials
7.2 , Ellex Medical Lasers Ltd. Company Overview
Product & Services, Strategies & Financials
7.3 Hoya Corporation Company Overview
Product & Services, Strategies & Financials
7.4 Novagali Pharma S A. Company Overview
Product & Services, Strategies & Financials
7.5 Abbott Medical Optics, Inc Company Overview
Product & Services, Strategies & Financials
7.6 Now Health Groups, Inc. Company Overview
Product & Services, Strategies & Financials
7.7 Essilor International SA Company Overview
Product & Services, Strategies & Financials
7.8 Vision Inc. Company Overview
Product & Services, Strategies & Financials
7.9 Nidek Co.Ltd, Inc Company Overview
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Pricing and Reimbursement scenario of OTC Ophthalmology Products market
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development of OTC Ophthalmology Products market
9.2 Future Opportunities
10. Strategic Recommendations

OTC Ophthalmology Product Market Segmentation

By Therapeutic Class Analysis:

  • Anti-inflammatory Drugs
  • Anti-infective Drugs
  • Anti-glaucoma Drugs
  • Anti-allergy Drugs
  • Anti-VEGF Agents
  • Others

By Product Type:

  • Prescription Drugs
  • Over-the-Counter Drugs

By Distribution Channel:

  • Hospital Pharmacies
  • Online Pharmacies
  • Independent Pharmacies
  • Drug Stores

By Disease Indications:

  • Dry Eyes
  • Glaucoma
  • Infection/Inflammation
  • Retinal Disorders
  • Allergy
  • Uveitis
  • Others

By Dosage Form:

  • Liquid Ophthalmic Drugs Forms
  • Solid Ophthalmic Drugs Forms
  • Semisolid Ophthalmic Drugs
  • Multicompartment Drug Delivery System

By Technology:

  • Biologics
  • Cell Therapy
  • Gene Therapy
  • Drug Therapy
  • Small Delivery
  • Small Molecule
  • Others

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements